Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The US market for regenerative medicine therapies consists of relatively new products in expanding markets and emerging technologies that will form new segments. The market is expected to undergo enormous growth once the first products enter the market due to the high prices of these therapies and the large patient populations for the treatments, as well as their ability to address the unmet needs of patient populations with rare diseases for which there are few alternative treatments.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for regenerative medicine in the US across a 10-year period, with additional coverage through 2027 for some segments.